Biologics·Aug 6, 2026
Exosomes: A Patient FAQ That Doesn't Overclaim
Straight patient answers on exosome therapy — what they are, what they can honestly do, and how to tell a serious provider from a marketing pitch.
Read guide →RegenTruth Blog
Field notes from the frontier of regenerative medicine.
Perspectives on biologics, energy-based devices, industry trends, and the practitioners shaping the future of care.
Biologics·Aug 5, 2026
Exosome Protocols: Topical, Micro-Channel & Post-Procedure Delivery
Practical exosome protocols across aesthetic, hair, wound, and adjunct applications with honest positioning inside U.S. regulatory framing.
Read guide →Biologics·Aug 4, 2026
Exosomes: The Cell-Free Biology That Is Reshaping Regenerative Medicine
Vesicle biogenesis, cargo, MISEV 2023 characterization standards, and how cell-free signaling reshapes the therapeutic and regulatory landscape.
Read guide →Biologics·Aug 3, 2026
Mesenchymal Stem Cells: A Patient FAQ That Actually Answers the Hard Questions
Candid patient answers on MSC therapy — is it legal, does it work, what about clinics abroad, how to tell honest providers from marketing.
Read guide →Biologics·Aug 2, 2026
MSC-Based Protocols: What U.S. Practices Can Safely Do Today
A framework for MSC-based protocols within U.S. regulatory framing — same-day autologous delivery, sequencing, and honest patient positioning.
Read guide →Biologics·Aug 1, 2026
Mesenchymal Stem Cells (MSCs): What They Are, What They Do, and Why the U.S. Market Is Complicated
The biology of MSCs — paracrine signaling, homing, immunomodulation — and why culture-expanded allogeneic products remain investigational in the U.S.
Read guide →Biologics·Jul 31, 2026
Autologous Stem Cell Therapy: What Patients Should Ask Before Signing Up
A candid patient FAQ on autologous BMAC and adipose therapy — what it is, red flags, cost, and how to tell the real thing from the marketing.
Read guide →Biologics·Jul 30, 2026
Autologous Cell Protocols: BMAC & Adipose in Orthopedic and Wound Practice
Harvest technique, cell yield targets, delivery, device sequencing, and where autologous fits against PRP and amniotic alternatives.
Read guide →Biologics·Jul 29, 2026
Autologous Stem Cells: BMAC, ADSC & SVF — What Each Preparation Actually Is
The cellular biology and regulatory framing of BMAC, adipose-derived cells, and SVF — and why paracrine signaling is the dominant mode of action.
Read guide →Biologics·Jul 28, 2026
Amniotic Therapy: A Patient FAQ — Ethics, Safety, and What to Expect
Straight patient answers on amniotic biologics — sourcing, ethics, safety, comparison with stem cells, and how to spot bad suppliers.
Read guide →Biologics·Jul 27, 2026
Amniotic Product Protocols: Wound Care, Aesthetics & Orthopedic Use
Application, coverage volume, sequencing with dermal infusion and microneedling, and comparisons with PRP and exosome pairings.
Read guide →Biologics·Jul 26, 2026
Amniotic Biologics: The Science of ECM, Growth Factors & Immunoprivilege
Mechanism, composition, format differences, and 361 HCT/P regulatory framing for amniotic membrane and fluid biologics.
Read guide →Biologics·Jul 25, 2026
PRP: The Consult-Room Patient FAQ
Plain-language answers to what patients ask about PRP — pain, sessions, hair loss, joints, aesthetics, and how to spot a bad provider.
Read guide →Biologics·Jul 24, 2026
PRP Protocols by Indication: Draw, Spin, Prep, Deliver
Working PRP protocols across orthopedic, urologic, aesthetic, and hair-loss indications with concentration and delivery specifics.
Read guide →Biologics·Jul 23, 2026
Platelet-Rich Plasma (PRP): The Cell Biology That Actually Drives Outcomes
Platelet activation, growth factor cascades, PRP vs PRP-PRFM, leukocyte-rich vs leukocyte-poor — the science under the marketing.
Read guide →Devices·Jul 22, 2026
Cold Laser / LLLT: A Patient FAQ for Modern Regenerative Clinics
The most-asked LLLT patient questions — is it real, does it beat home red-light panels, does it grow hair, what will I feel?
Read guide →Devices·Jul 21, 2026
LLLT / Diode Laser Protocols: Wavelength, Fluence, Cadence & Practical Recipes
Working LLLT protocols for wound care, oral mucositis, hair loss, TMJ, post-procedure recovery, and superficial neuropathies.
Read guide →Devices·Jul 20, 2026
Low-Level Laser Therapy (LLLT / Diode Lasers): The Photobiology of Gentle Doses
Where LLLT lives on the dose–response curve, why more power is not always better, and where each wavelength earns its place.
Read guide →Devices·Jul 19, 2026
Class IV Laser Therapy: What Patients Ask in the Consult Room
Plain-language patient FAQ on HPLT — safety, sensations, timelines, indications, and comparisons with alternatives.
Read guide →Devices·Jul 18, 2026
HPLT Protocols by Indication: Wavelength, Fluence, Cadence & Comparisons
Working Class IV laser protocols across MSK, neuropathic, post-surgical, and aesthetic care — plus LLLT and ECSWT positioning.
Read guide →Devices·Jul 17, 2026
High Power Laser Therapy (HPLT): Photobiomodulation at Clinical Doses
Cytochrome c oxidase activation, nitric oxide release, thermal contribution, and why more power changes the therapeutic ceiling.
Read guide →Devices·Jul 16, 2026
Microneedling: What Patients Actually Want to Know
The consult-room FAQ for microneedling — pain, downtime, dark-skin safety, PRP add-ons, cost, and at-home rollers.
Read guide →Devices·Jul 15, 2026
Microneedling Protocols by Indication: Depth, Passes, Serum & Cadence
Working microneedling settings across rejuvenation, acne scars, melasma, striae, hair loss — with head-to-heads.
Read guide →Devices·Jul 14, 2026
Microneedling: The Cellular Biology of Collagen Induction Therapy
The wound-healing cascade behind CIT, needle depth thresholds, and where RF-microneedling changes the game.
Read guide →Devices·Jul 13, 2026
Fractional Dermal Infusion: A Consult-Room FAQ
What patients ask about dermal infusion — feel, downtime, indications, comparisons with microneedling and lasers, longevity of results.
Read guide →Devices·Jul 12, 2026
Fractional Dermal Infusion Protocols: Face, Neck, Scalp & Body
Depth, vacuum, serum, and cadence recipes across rejuvenation, melasma, acne scars, alopecia, and post-procedure recovery.
Read guide →Peptide Therapy·Jul 12, 2026
How to Train Staff on Peptide Protocols (A 2026 Curriculum)
A 6-week curriculum for MA / RN / NP staff — pharmacology, injection technique, monitoring, documentation, and competency sign-off.
Read guide →Devices·Jul 11, 2026
Fractional Dermal Infusion: How the Dermal–Epidermal Junction Becomes a Delivery Target
The biophysics of micro-channels, negative pressure, and formulation viscosity that deliver biologics to the DE junction reproducibly.
Read guide →Biologics·Jul 11, 2026
Legal Issues with Regenerative Biologics in U.S. Clinics (2026)
HCT/Ps, 361 vs 351, exosomes, compounded peptides, off-label use, state boards, and the marketing claims that reliably trigger enforcement.
Read guide →Devices·Jul 10, 2026
Shockwave Therapy: A Patient FAQ for Practitioners to Share
The 25 questions patients actually ask about shockwave — pain, downtime, safety, timelines and cost — in a consult-room voice.
Read guide →Devices·Jul 10, 2026
How to Add Shockwave Therapy to a Urology Practice (2026 Playbook)
Step-by-step 2026 playbook — device choice, room, staffing, protocols, consent, coding, and realistic ROI for adding focused LiSWT to a urology practice.
Read guide →Devices·Jul 9, 2026
ECSWT Protocols by Indication: Energy, Pulses, Cadence & Comparisons
Concrete energy flux density, pulse counts, session cadence and head-to-head positioning for the most common ECSWT indications.
Read guide →Devices·Jul 8, 2026
How Extracorporeal Shockwave Therapy (ECSWT) Actually Works
The clinical science behind focused and radial shockwave — cavitation, mechanotransduction, angiogenesis, and the evidence base across MSK, urologic, and aesthetic care.
Read guide →Peptide Therapy·Jul 8, 2026
Peptide Therapy for Weight Loss: A Clinical Protocol Guide
A B2B clinical guide covering GLP-1 agonists, GH secretagogues, dosing, contraindications, and patient monitoring for practice-based weight management.
Read guide →State of Regenerative·Jun 3, 2026
2026 State of Regenerative Medicine: Annual Practitioner Survey
1,850+ providers weigh in on peptide adoption, exosome sourcing, device ROI, and AI-driven decision support entering its second year of mainstream practice.
Peptide Therapy·May 12, 2026
Retatrutide, Survodutide & the Next Wave: 2026 GLP-1 Landscape
Head-to-head efficacy, tolerability, and payer coverage across triple agonists and next-generation dual agonists — what to add to your service line in 2026.
Biologics·Apr 8, 2026
Exosome Characterization Standards: MISEV 2023 in Practice
How to read a Certificate of Analysis, what particle counts and tetraspanin ratios mean, and the vetting checklist DRS uses on every 2026 exosome lot.
Devices·Mar 22, 2026
Zimmer Z Wave Two Years In: Clinical Outcome Roundup
Aggregated outcome data from 180+ DRS-supported clinics using radial shockwave across MSK, urologic, and aesthetic indications.
Supplies & PPE·Feb 14, 2026
PPE Supply Chain in 2026: Back to Normal — Mostly
Pricing has normalized, but nitrile gloves and specialty injection supplies still see periodic tightness. How DRS is buffering clinic inventories.
Biologics·Jul 30, 2022
Exosomes
Exosomes are small vesicles secreted by most cell types that facilitate intercellular communication — delivering lipids, proteins, and nucleic acids to neighboring and distant cells.
State of Regenerative·Dec 10, 2020
Bad Actors: The Greatest Risk to Regenerative Medicine
More than half of respondents point to bad actors — from unethical suppliers to ill-informed practitioners — as the biggest threat to the industry.
Bring regenerative medicine into your practice.
Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.